Abstract
Parkinson's disease (PD) is a condition that predominantly affects older people. It is imperative that clinical management considers the other significant illnesses that people with PD accumulate as they age in conjunction with their resilience to cope with physiological change. Multimorbidity and frailty act synergistically to heighten the risk of adverse outcomes for older people with PD. These states are associated with increased likelihood of hospitalisation, polypharmacy, adverse drug effects including the anticholinergic burden of medications, drug-disease and drug-drug interactions. Management should be integrated, holistic and individualised to meticulously balance the risks of interventions considering the vulnerability of the individual to recover from disturbance to their environmental, physical and cognitive equilibrium.
Original language | English |
---|---|
Journal | Journal of Parkinson's Disease |
Early online date | 29 Jul 2020 |
DOIs | |
Publication status | E-pub ahead of print - 29 Jul 2020 |
Research Groups and Themes
- Ageing and Movement Research Group